APAC Laboratory-Developed Tests (LDTs) Market - Industry Trends and Forecast to 2030
The Asia-Pacific Laboratory-Developed Tests (LDTs) market is expected to reach USD 9,607.08 Million by 2030 from USD 4,768.52 million in 2022, growing at a CAGR of 9.2% during the forecast period of 2023 to 2030.
Market SegmentationAsia-Pacific Laboratory-Developed Tests (LDTs) Market, By Test Type (Clinical Chemistry and Immunology, Critical Care, Hematology, Molecular Diagnostics, Microbiology, and Other Test), Product Type (Consumables, Analyzers and Instruments, and Accessories), Sample Type (Blood, Urine, Tissue, Cerebrospinal Fluid (CSF), and Others), Therapeutic Area (Infections, Genetic Disorders, Oncology/Cancer, Autoimmune Disease, Urology, Gynecology, and Others), Gender (Male, and Female), Age Group (Geriatrics, Adult, and Pediatric), End Users (Hospital-Based Labs, Stand-Alone Labs, Diagnostic Chains, Academic Institutes, Clinical Research Organizations, Specialty Diagnostic Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, Third Party Distributors, and Others), Country (China, Japan, India, Australia, South Korea, Indonesia, Philippines, Thailand, Malaysia, Singapore, Rest of Asia Pacific) - Industry Trends and Forecast to 2030
Overview of Asia-Pacific Laboratory-Developed Tests (LDTs) Market DynamicsDrivers
• Increasing demand for personalized medicines
• Advancements in molecular diagnostics
Restraint
• Stringent quality control and standardization for LDTs
Opportunity
• Increasing demand for precision medicine and targeted therapy
Market PlayersSome of the major market players operating in the Asia-Pacific Laboratory-Developed Tests (LDTs) market are:• F. Hoffmann-La Roche Ltd
• bioMérieux, Inc.
• Sysmex Corporation
• Biomerica, Inc.
• Bio-Rad Laboratories, Inc.
• Abbott
• Siemens Medical Solutions USA, Inc.
• Quest Diagnostics Incorporated
• QIAGEN
• Eurofins Scientific
• Biodesix.
• Hologic, Inc.
• Guardant Health
• OPKO Health, Inc.
• BD
• Beckman Coulter, Inc.
• NeoGenomics Laboratories.
• Seegene Inc.
• BGI
• 23andMe, Inc.
• Agendia